Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study (years) |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | galactose | 9998 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | galactose | 17337 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | galactose | 17617 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 5 |
GC POSITIVE ION MODE | galactose | 18184 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 7 |
GC POSITIVE ION MODE | galactose | 20600 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 7 |
GC POSITIVE ION MODE | galactose | 27866 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
GC POSITIVE ION MODE | galactose | 31834 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
GC POSITIVE ION MODE | galactose | 38568 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
GC POSITIVE ION MODE | galactose | 38594 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
GC POSITIVE ION MODE | galactose | 43251 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
GC POSITIVE ION MODE | galactose | 49795 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | galactose | 56805 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | galactose | 56930 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | galactose | 57862 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | galactose | 58226 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
GC POSITIVE ION MODE | galactose | 65955 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
GC POSITIVE ION MODE | galactose | 66445 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | galactose | 69133 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | galactose | 70006 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
GC POSITIVE ION MODE | galactose | 76224 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | galactose | 76998 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
GC POSITIVE ION MODE | galactose | 79453 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | galactose | 83812 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | galactose | 84662 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | galactose | 85492 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 5 |
GC POSITIVE ION MODE | galactose | 85495 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
GC POSITIVE ION MODE | galactose | 90191 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | galactose | 90956 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | galactose | 91431 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | galactose | 91917 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
GC POSITIVE ION MODE | galactose | 92682 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | galactose | 94587 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | galactose | 94667 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
GC POSITIVE ION MODE | galactose | 96209 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | galactose | 106831 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 10 |
GC POSITIVE ION MODE | galactose | 107185 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
GC POSITIVE ION MODE | galactose | 110560 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | galactose | 112792 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 7 |
GC POSITIVE ION MODE | galactose | 123176 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | galactose | 125740 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
GC POSITIVE ION MODE | galactose | 138003 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 10 |
GC POSITIVE ION MODE | galactose | 143129 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | galactose | 164648 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 10 |
GC POSITIVE ION MODE | galactose | 171996 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | galactose | 175994 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 9 |
GC POSITIVE ION MODE | galactose | 176648 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
GC POSITIVE ION MODE | galactose | 186150 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
GC POSITIVE ION MODE | galactose | 224367 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 5 |
GC POSITIVE ION MODE | galactose | 225747 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
GC POSITIVE ION MODE | galactose | 699212 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
GC POSITIVE ION MODE | galactose | 987538 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 5 |
GC POSITIVE ION MODE | galactose | 1232723 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
GC POSITIVE ION MODE | galactose | 1304419 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 7 |
GC POSITIVE ION MODE | galactose | 2812979 | Counts | NA | NA | NA | - |